(Q37736019)

22 August 2017

1 reference

title

A systematic review of national immunization policy making processes (English)

1 reference

22 August 2017

0 references

1 reference

Maggie Bryson

1

1 reference

22 August 2017

Philippe Duclos

series ordinal

2

1 reference

22 August 2017

Ann Jolly

series ordinal

3

1 reference

22 August 2017

Jessica Bryson

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

28 Suppl 1

1 reference

22 August 2017

page(s)

A6-12

1 reference

MMR mass vaccination campaigns, vaccine-related adverse events, and the limits of the decision making process, in Brazil.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

What influences government adoption of vaccines in developing countries? A policy process analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Vaccine independence, local competences and globalisation: lessons from the history of pertussis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

The role of economic information in decision-making by the Advisory Committee on Immunization Practices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

The structure and function of immunization advisory committees in Western Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Adopting immunization recommendations: a new dissemination model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

The need for an evidence-based decision-making process with regard to control of hepatitis A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Priorities among effective clinical preventive services: results of a systematic review and analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Development of priority vaccines for disease-endemic countries: risk and benefit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Development of immunization policy and its implementation in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Impact of influenza on young children and the shaping of United States influenza vaccine policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

Slow but steady progress in child health in Papua New Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

The meningococcal vaccine--public policy and individual choices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

An analytical framework for immunization programs in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.026

10.1016/J.VACCINE.2010.02.026

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference